Feil Family Brain & Mind Research Institute

Publications

Found 830 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is S  [Clear All Filters]
2023
Simonetto M, Sheth KN, Ziai WC, Iadecola C, Zhang C, Murthy SB.  2023.  Racial and Ethnic Differences in the Risk of Ischemic Stroke After Nontraumatic Intracerebral Hemorrhage.. Stroke. 54(9):2401-2408.
Larivière D, Abueg L, Brajuka N, Gallardo-Alba C, Grüning B, Ko BJune, Ostrovsky A, Palmada-Flores M, Pickett BD, Rabbani K et al..  2023.  Scalable, accessible, and reproducible reference genome assembly and evaluation in Galaxy.. bioRxiv.
Larivière D, Abueg L, Brajuka N, Gallardo-Alba C, Grüning B, Ko BJune, Ostrovsky A, Palmada-Flores M, Pickett BD, Rabbani K et al..  2023.  Scalable, accessible, and reproducible reference genome assembly and evaluation in Galaxy.. bioRxiv.
Larivière D, Abueg L, Brajuka N, Gallardo-Alba C, Grüning B, Ko BJune, Ostrovsky A, Palmada-Flores M, Pickett BD, Rabbani K et al..  2023.  Scalable, accessible, and reproducible reference genome assembly and evaluation in Galaxy.. bioRxiv.
Joglekar A, Hu W, Zhang B, Narykov O, Diekhans M, Balacco J, Ndhlovu LC, Milner TA, Fedrigo O, Jarvis ED et al..  2023.  Single-cell long-read mRNA isoform regulation is pervasive across mammalian brain regions, cell types, and development.. bioRxiv.
Sasset L, Chowdhury KH, Manzo OL, Rubinelli L, Konrad C, J Maschek A, Manfredi G, Holland WL, Di Lorenzo A.  2023.  Sphingosine-1-phosphate controls endothelial sphingolipid homeostasis via ORMDL.. EMBO Rep. 24(1):e54689.
Fins JJ, Wright MS, Shulman KS, Henderson JM, Schiff ND.  2023.  Subject and Family Perspectives from the Central Thalamic Deep Brain Stimulation Trial for Traumatic Brain Injury: Part II.. Camb Q Healthc Ethics. :1-24.
Fins JJ, Wright MS, Shulman KS, Henderson JM, Schiff ND.  2023.  Subject and Family Perspectives from the Central Thalamic Deep Brain Stimulation Trial for Traumatic Brain Injury: Part II.. Camb Q Healthc Ethics. :1-24.
Chiu Y-T, Deutch AY, Wang W, Schmitz GP, Huang KLu, D Kocak D, Llorach P, Bowyer K, Liu B, Sciaky N et al..  2023.  A suite of engineered mice for interrogating psychedelic drug actions.. bioRxiv.
Chiu Y-T, Deutch AY, Wang W, Schmitz GP, Huang KLu, D Kocak D, Llorach P, Bowyer K, Liu B, Sciaky N et al..  2023.  A suite of engineered mice for interrogating psychedelic drug actions.. bioRxiv.
Chiu Y-T, Deutch AY, Wang W, Schmitz GP, Huang KLu, D Kocak D, Llorach P, Bowyer K, Liu B, Sciaky N et al..  2023.  A suite of engineered mice for interrogating psychedelic drug actions.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Schiff ND, Giacino JT, Butson CR, Choi EYoung, Baker JL, O'Sullivan KP, Janson AP, Bergin M, Bronte-Stewart HM, Chua J et al..  2023.  Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study.. Nat Med.
Schiff ND, Giacino JT, Butson CR, Choi EYoung, Baker JL, O'Sullivan KP, Janson AP, Bergin M, Bronte-Stewart HM, Chua J et al..  2023.  Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study.. Nat Med.
Schiff ND, Giacino JT, Butson CR, Choi EYoung, Baker JL, O'Sullivan KP, Janson AP, Bergin M, Bronte-Stewart HM, Chua J et al..  2023.  Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study.. Nat Med.
Nair RSathish, Kumar S, Das S, Singh SKumar, Srivastava P, Sondarva G, Rao A, Sinha SC, Xiong R, Bloem L et al..  2023.  TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer.. Oncogene.
Nair RSathish, Kumar S, Das S, Singh SKumar, Srivastava P, Sondarva G, Rao A, Sinha SC, Xiong R, Bloem L et al..  2023.  TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer.. Oncogene.
Nair RSathish, Kumar S, Das S, Singh SKumar, Srivastava P, Sondarva G, Rao A, Sinha SC, Xiong R, Bloem L et al..  2023.  TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer.. Oncogene.
Nair RSathish, Kumar S, Das S, Singh SKumar, Srivastava P, Sondarva G, Rao A, Sinha SC, Xiong R, Bloem L et al..  2023.  TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer.. Oncogene.